Update following the UK Motor Finance commission Supreme Court ruling Ayvens welcomes the clarity of the UK Supreme Court judgment dated 1 August 2025 relating to UK Motor Finance Commission. Ayvens' initial analysis of such judgment and of the Financial Conduct Authority’s (FCA) announcement on 3rd August 2025 that it intends to consult on a redress scheme is that the provision recorded in its 2024 financial statements (as disclosed in Ayvens' Universal Registration Document for 2024) for the potential liabilities relating to the UK motor finance commissions exposure remains adequate. A...
AB InBev: 2Q25 results. Air France-KLM: Nice beat, let's see how FY25 finishes. AMG: Uptrend continues in 2Q25 with 23% EBITDA beat and guidance up to +US$200m. Aperam: Slight 2Q25 EBITDA beat, 3Q25 seen down QoQ. Arcadis: EBITA margin held up well in 2Q25, order intake mixed. Ayvens: 2Q25 results. Azelis: Soft but largely in-line 2Q25 with EMEA offsetting weaker APAC. Bekaert: 1H25 miss and lowered outlook to result in c.5% consensus downside. Corbion: Taking it to the wire. dsm...
Strong Q2 2025 financial results, PowerUp 2026 progressing according to plan Q2 2025 RESULTS1 Net income group share at EUR 271 million, up 38.5% vs. Q2 2024 Return on Tangible Equity (ROTE) at 13.7% vs. 10.1% in Q2 2024Earnings per share2 at EUR 0.30 up 42.4% vs. Q2 2024 Leasing and Services margins at EUR 712 million, up 3.7% vs. Q2 2024Underlying margins3 at 550 bps of average earning assets vs. 539 bps in Q2 2024 Used car sales (UCS) result and Depreciation adjustments at EUR 143 million up 45.9% vs. Q2 2024 Synergies4 at EUR 86 million in Q2 2025, up from EUR 27 million in Q2 20...
Although the uncertainty surrounding EV residual values has not disappeared, this risk is now less critical thanks to the conservative pricing policy adopted since the end of 2023, versus an EPS CAGR of +24% over 2024-2027. Coupled with the successful execution of synergies, we have significantly upgraded our target price to € 12 from € 6.0 (lower cost of capital) and our rating to Outperform from Neutral.
Si l‘incertitude liée à la valeur résiduelle des EV n’a pas disparu, ce risque est désormais moins critique, grâce à la politique de pricing conservatrice depuis fin 2023, et face à un TMVA 2024-2027 des BPA de +24%. Couplé à la bonne exécution des synergies, nous relevons sensiblement notre OC à 12 € vs 6.0 € (coût du capital plus faible) et notre opinion à Surperformance vs Neutre.
Appointment of Philippe de Rovira as Chief Executive Officer of Ayvens The Board of Directors of Ayvens is pleased to announce the appointment of Philippe de Rovira as Chief Executive Officer (“Directeur Général”) following the recommendation of the Nomination Committee as part of its succession planning exercise. This appointment will become effective on 1st December 2025. Philippe de Rovira is due to be appointed by cooptation as member of the Board of Directors of Ayvens upon his taking responsibility as Chief Executive Officer of Ayvens. Tim Albertsen has informed the Board of Director...
Notification of MREL requirements Ayvens has received the notification by the Autorité de Contrôle Prudentiel et de Resolution (ACPR), implementing the decision of the Single Resolution Board on the Minimum Requirement for Own Funds and Eligible Liabilities (MREL) requirements applicable from 31 December 2026. The total MREL requirement amounts to 19.95% of the Ayvens Group’s RWA, to which the CBR1 must be added, and 5.91% of the Ayvens Group’s leverage ratio exposure. Ayvens, being a non-resolution entity within the Societe Generale resolution group, intends to increase its eligible ...
Description of Ayvens share buyback programme Approved by the combined General Meeting dated 19 May 2025 This description is drawn up in accordance with the provisions of Articles 241-1 and 241-2 I of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers). Date of the General Meeting called to approve the share buyback programme The authorisation for the Company to buy its own shares was approved at the combined General Shareholders' Meeting dated 19 May 2025. Breakdown by objective of the securities held As at 15 May 2025, Ayvens held...
Alfen: Dead cat bounce? Ayvens: Overhang cure. Belgian telcos: Hey! discontinues €5 offer, OBEL price increases from June 2025. B&S Group: Pulls FY EBITDA guidance in light of tariffs. D'Ieteren: CMD, 1Q25 Preview. Kendrion: Wrestling through difficult macro conditions. NN Group, ASR: Vote on Dutch pension reforms postponed. TKH Group: Not that bad, good progress at Eemshaven. UCB: US Most Favoured Nation initiative back on the agenda. Vastned: Good results, integration ongoing...
Information regarding transactions executed within the framework of a share buyback program (outside the liquidity agreement) Ayvens reports share buyback transactions executed on 7 May 2025 under Article 5 of Regulation (EU) No 596/2014 on Market Abuse Regulation and Article 3(3) of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 through regulatory technical standards concerning the conditions applicable to buyback programs and stabilization measures. The transactions are part of the share buyback program authorized by the combined General Meeting dated 14 Ma...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.